Good advice for the path to digital production

SMEs trying to get their companies ready for digital production quickly find themselves faced with major tasks. This is where Siemens' new Digitalization Consulting concept comes in. Dr. Raphael Vogler, CEO of the ChemCon GmbH pharmaceutical company, discusses the special challenges faced by small and medium-sized pharmaceutical manufacturers and his collaboration with Siemens on the path to digitalization.

Dr. Vogler, ChemCon is a fast-growing enterprise in the pharmaceutical industry. What are your key features?


Dr. Raphael Vogler: ChemCon fills the niche of producing specialty chemicals and drug substances in small quantities. Many pharmaceutical and biotechnology companies seek manufacturing partners for substances with an annual demand of less than a few hundred kilograms. The production of such small quantities is often too expensive to be profitable. With an innovative production concept, we turned this challenging task into a successful contract manufacturing service. In addition, we recently began offering comprehensive, in-house chemical analytical services independently from production. We are also very proud that critically ill patients worldwide now benefit from the substances manufactured here at ChemCon.

It was Siemens’ initiative to offer us a comprehensive digital consulting approach rather than isolated solutions.
Dr. Raphael Vogler, ChemCon GmbH

What are ChemCon’s primary challenges in times of digitalization?


Vogler: The production of active pharmaceutical ingredients is strictly regulated to ensure consistent documentation and data integrity. Existing digital solutions compliant with US-FDA (Food and Drug Administration) regulations used to be very challenging for our small-volume, hands-on projects. Instead, we chose to use paper-based cGMP* documentation. But we often joke that one kilogram of product is delivered with ten kilograms of paper, which often wasn’t even an exaggeration. Today we have reached a size where digitalized processes will bring a huge advantage to grow and to compete in the global market. For an SME like ChemCon, with about 100 members of staff, the step away from paper towards fully integrated digital solutions is enormous, both in terms of work expenditure and financial resources. However, industrial standards have since been developed to help pharmaceutical companies on their path to digitalization. And this is where the Siemens digitalization consulting project came in.

You chose Siemens as a Consulting Partner to start your Road to Digitalization. Why Siemens?


Vogler: Siemens is known for its extensive experience and domain expertise in optimizing pharmaceutical processes. Actually, several different aspects convinced us. Initially, we contacted Siemens for a number of individual technical solutions, including a labor information and management system, to manage our Analytical Services. It was Siemens’ initiative to offer us a comprehensive digital consulting approach rather than isolated solutions. A very deep analysis of our internal processes ensured that the proposed solutions could be perfectly adjusted to our requirements and capabilities. We also benefited from Siemens’ exemplary support through its regional sales organization in Freiburg. They immediately understood the challenges we face as an SME and kept them in mind at all times.

Siemens immediately understood the challenges we face as an SME.
Dr. Raphael Vogler, ChemCon GmbH

Did any aspect of the collaboration with Siemens strike you as particularly inspiring?


Vogler: We were positively surprised by the extremely neutral and customer orientated approach of the Siemens consultants. One might expect that consultants from such a large corporate organization might promote their own products and technical solutions. This was certainly not the case. On the contrary: The methodology and the quick comprehension of the challenges of digitalizing a cGMP-regulated organization struck us as extremely helpful. Proposed technical solutions were always well researched and took into account different suppliers. ChemCon is extremely quality driven. Siemens understood this necessity and met our high-quality demands with an equally high-quality, tailor-made service.

What are the most important milestones for yourself and your team in the implementation of the digital roadmap?


Vogler: Siemens’ digital roadmap provides us with a clear schedule how to improve our processes through validated digital systems while maintaining full data integrity. This is an extremely important step for us to continue to grow in an increasingly digitized industrial environment. And our customers can continue to rely on ChemCon as a reliable partner with high-quality products. With the digital roadmap, Siemens has started a long-term project for ChemCon. Although the project management will now be centered at ChemCon, we will certainly continue our collaboration with Siemens. We are convinced that in the future milestone meetings will be crucial in helping ChemCon to succeed in its stated goal of significantly increased productivity through digitalization. 

*cGMP (current Good Manufacturing Practice):
An aspect of quality assurance, which guarantees that products are uniformly produced and tested according to quality standards that meet the product's intended use and are in compliance with the approval documentation. Good manufacturing practice applies to both production and quality control.
Source: Translated from

ChemCon is a medium-size enterprise located in Freiburg, Germany. ChemCon's labs, clean rooms, analytics and quality assurance are ideally suited to the production of active pharmaceutical ingredients in clinical trials or commercial substances with low annual demand. Applications include orphan diseases, critical and post-operative care, ophthalmology, or oncology. ChemCon also supplies high-value fine chemicals of the highest purity on demand.

With more than 4,300 m² of operational space, ChemCon is now the biggest privately owned company within the Innovation center at the Industrial Park North in Freiburg. The ever-growing company is constantly creating new jobs locally and has been a recognized training center for many years. The company was founded on January 29, 1997, when Dr. Raphael Vogler (CEO) and Dr. Peter Gockel (CSO) signed the partnering contract for an independent chemical consulting company.

Subscribe to our Newsletter

Stay up to date at all times: everything you need to know about electrification, automation, and digitalization.